Effects of 4 weeks of atorvastatin administration on the antiinflammatory cytokine interleukin-10 in patients with unstable angina

Clinical Chemistry

Volumn 51, Issue 9, 2005, Pages 1735-1738

  Li, Jian Jun ^a   Fang, Chun Hong ^b  

^a FUWAI HOSPITAL   (China)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CYTOKINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 10; PLACEBO; STATIN;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DRUG EFFECT; ECHOCARDIOGRAPHY; FEMALE; HIGH RISK PATIENT; HUMAN; MALE; RISK ASSESSMENT; ST SEGMENT ELEVATION; UNSTABLE ANGINA PECTORIS;

ANGINA, UNSTABLE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INTERLEUKIN-10; PYRROLES;

EID: 24144496188     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.049700     Document Type: Article

References (28)

1. Maseri A. Inflammation, atherosclerosis, and ischemic events: exploring the hidden side of the moon. N Engl J Med 1997;336:1014-6.
2. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1993; 340:115-26.
3. Libby P, Ridker PM. Novel inflammatory markers of coronary risk: theory versus practice. Circulation 1999;100:1148-50.
4. Li J-J, Fang C-H. C-Reactive protein is not only a marker but also direct cause of cardiovascular disease. Med Hypotheses 2004;62:499-506.
5. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 1994;331:417-24.
6. Morrow DA, Rifai N, Antman EM. C-Reactive protein is a potent predicator of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. J Am Coll Cardiol 1998;31:1460-5.
7. Li J-J, Wang H-R, Huang C-X, Xue J-L, Li G-S. Enhanced response of blood monocytes to C-reactive protein in patients with unstable angina. Clin Chim Acta 2005;352:127-33.
8. Smith DA, Irving SD, Sheldon J, Kaski JC. Serum levels of the anti-inflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation 2001;104:746-50.
9. Alam SE, Nasser SS, Fernainy KE, Habib AA, Badr KF. Cytokine imbalance in acute coronary syndrome. Curr Opin Pharmacol 2004;4:166-70.
10. Heeschen C, Dimmeler S, Hamm CW, Fichtlscherer S, Boersma E, Simoons ML. Serum level of the anti-inflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 2003;107:2109-14.
11. Mizia-Stec K, Gasior Z, Zahorska-Markiewiez B, Janowska J, Szulc A, Jastrzebska-Maj E, et al. Serum tumor necrosis factor-α, interleukin-2 and interleukin-10 activation in stable angina and acute coronary syndromes. Coron Artery Dis 2003;14:431-8.
12. Fichtischerer S, Breuer S, Heeschen C, Dimmeler S, Zeiher A. Interleukin-10 serum levels and systemic endothelial vasoreactivity in patients with coronary artery disease. J Am Coll Cardiol 2004;44:50-2.
13. Schieffer B, Bunte C, Witte J, Hoeper K, Boger RH, Schwedhelm E, et al. Comparative effects of anti-antagonism and angiotensin converting enzyme inhibition on markers of inflammation, platelet aggregation in patients with coronary disease. J Am Coll Cardiol 2004;44:362-8.
14. Plenge JK, Hernandez TL, Weil KM, Poirier P, Grunwald GK, Marcovina SM, et al. Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction. Circulation 2002;106:1447-52.
15. Li J-J, Chen M-Z, Chen-X, Fang C-H. Rapid effects of simvastatin on lipid profile and C-reactive protein in patients with hypercholesterolemia. Clin Cardiol 2003;26:472-6.
16. Li J-J, Chen X-J. Simvastatin inhibits interleukin-6 release in human monocytes stimulated by C-reactive protein and lipopolysaccharide. Coron Artery Dis 2003;14:329-34.
17. Ridker PM, Rifai N, Lowenthal SP. Rapid reduction in C-reactive with cerivastatin among 785 patients with primary hypercholesterolemia. Circulation 2001;103:1191-3.
18. Li J-J, Jiang H, Huang C-X, Fang C-H, Tang Q-Z, Xiao H, et al. Elevated levels of plasma C-reactive protein in patients with unstable angina: its relations with coronary stenosis and lipid profile. Angiology 2002;53:265-72.
19. Li J-J, Fang C-H, Cheng M-Z, Cheng X. Activation of nuclear factor-κB and correlation with elevated plasma C-reactive protein in patients with unstable angina. Heart Lung Circ 2004;13:173-8.
20. Davis MJ. Stability and unstability: the two faces of coronary atherosclerosis. Circulation 1996;94:2013-20.
21. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes: implications for plaque rupture. Circulation 1994;90:775-80.
22. Wang P, Wu P, Siegel MI, Egan RW Billa MM. Interleukin (IL)-10 inhibits nuclear factor κB (NF κB) activation in human monocytes: IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem 1995; 270:9558-63.
23. Lacraz S, Nicod LP, Chicheortiche R, Welgus HG, Dayer JM. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest 1995;96:2304-10.
24. Lindmark E, Tenno T, Chen J, Siegbahn A. IL-10 inhibits LPS-induced human monocyte tissue factor expression in whole blood. Br J Haematol 1998; 102:597-604.
25. Arai T, Hiromatus K, Nishimura H, Kimura Y, Kobayashi N, Ishida H, et al. Endogenous interleukin 10 prevent apoptosis in macrophages during Salmonella infection. Biochem Biophys Res Commun 1995;213:600-7.
26. Pinderski LJ, Fishbein MP, Subbanagounder G, Fishbein MC, Kubo N, Cheroutre H, et al. Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient mice by altering lymphocyte and macrophage phenotypes. Circ Res 2002;90:1064-71.
27. Treasure CB, Klein JL, Weintraub WS, Talley JD, Stillabower ME, Kosinski AS, et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 1995;332:481-7.
28. Ridker PM, Rifai N, Pfeffer MA, Sacks F, Braunwald E. Long-term effects of pravastatin on plasma concentration of C-reactive protein. Circulation 1999;100:230-5.